Dr. Abou-Alfa on Emerging PD-L1 Agents in Liver Cancer

Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering, discusses what is on the horizon for the use of PD-L1 agents in liver cancer.